Ramseth to lead development of next-generation cellular orchestration platform in line with industry demand
Cardiff, UK, July 6, 2021 – TrakCel, the leading innovator of cellular orchestration solutions supporting the cell and gene therapy industry, today announces that Jason Ramseth has joined TrakCel’s executive leadership team as Chief Product Officer.
Ramseth brings to TrakCel over 19 years of experience acquired in senior bio-pharma Information Technology and customer experience roles. He recently served as Vice President, Customer Experience – Cell Therapy Development & Operations for Bristol Myers Squibb. In this role, Ramseth was responsible for driving ‘best in class’ customer experiences by leading cross-functional teams in critical path preparation for BMS’s first commercial cell therapy launch. Prior to BMS, Jason held several IT and commercial leadership positions of increasing levels of responsibility during a 15-year tenure with Amgen Corp.
Jason’s immediate responsibility will include driving TrakCel’s product roadmap and leveraging his experience in designing integrated value-add solutions for advanced therapy clients. TrakCel’s experience in managing the broadest range of therapeutic classes (CAR-T, MIL, TIL, PCV, CRISPR) in allogeneic and autologous settings has led to the development of the largest Module Library in the industry. Ramseth will oversee the strategic development of OCELLOS’ Module Library, particularly its Integration Hub module, which seamlessly connects cell and gene therapy service providers into OCELLOS’ digital ecosystem.
“Jason Ramseth will be a significant addition to TrakCel’s executive leadership team. He joins at a pivotal time for TrakCel as it introduces its next-generation, Salesforce-powered cellular orchestration platform, OCELLOS to the advanced therapy market. Combining his wide experience of IT systems and processes and his knowledge of commercial therapy implementation will be critical as TrakCel continues its mission of enabling the advanced therapy industry to standardize,” said Dr. Fiona Withey, Chief Executive Officer, TrakCel. “Jason’s appointment as Chief Product Officer will provide an additional boost to our strategic plan to continue innovating in every area of the TrakCel organization, and specifically our product offering. In OCELLOS, TrakCel is providing a cellular orchestration platform capable of offering a user experience that surpasses the expectations of all those involved in the industry.”
“I’ve chosen to join TrakCel at a key time for the organization. The recent general availability launch of OCELLOS by TrakCel demonstrates the company’s ability to develop innovative professional services required by the cell and gene therapy industry,” said Jason Ramseth, Chief Product Officer, TrakCel. “Joining TrakCel enables me to play a key role in designing and delivering exceptional customer experiences and technology solutions.”
TrakCel is the leading innovator of integrated technologies specifically created in 2012 to manage the international autologous and allogeneic cell, gene and immunotherapy supply chain. TrakCel’s software platform has been developed in collaboration with, and increasingly adopted by leading companies in cell, gene and immunotherapy industries. TrakCel’s solutions deliver real-time control over the entire therapeutic supply chain, from sample collection through to treatment delivery. The TrakCel platform accelerates global scale-up and scale-out of cell and gene therapy products, increasing efficiency and decreasing complexity, while maintaining treatment collection to administration compliance and traceability. TrakCel is headquartered in Cardiff, Wales, UK with US offices in California and New Jersey.
For more information about the TrakCel leadership team, visit our Exec biog. page.
Article by TrakCel Marketing - 6 Jul 2021